Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia
Hindlimb ischemia is an unmet medical need, especially for those patients unable to undergo vascular surgery. Cellular therapy, mainly through mesenchymal stromal cell (MSC) administration, may be a potentially attractive approach in this setting. In the current work, we aimed to assess the potentia...
Main Authors: | Arturo Ibáñez-Fonseca, Ana Rico, Silvia Preciado, Fernando González-Pérez, Sandra Muntión, Jesús García-Briñón, María-Carmen García-Macías, José Carlos Rodríguez-Cabello, Miguel Pericacho, Matilde Alonso, Fermín Sánchez-Guijo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.918602/full |
Similar Items
-
MSCs from polytrauma patients: preliminary comparative study with MSCs from elective-surgery patients
by: Raúl López, et al.
Published: (2021-08-01) -
Co-administration of human MSC overexpressing HIF-1α increases human CD34+ cell engraftment in vivo
by: Silvia Preciado, et al.
Published: (2021-12-01) -
Therapeutic potential of mesenchymal stromal/stem cells in critical‐care patients with systemic inflammatory response syndrome
by: Gerardo‐Javier Martí‐Chillón, et al.
Published: (2023-01-01) -
Effects of Dietary Supplementation with a Ferulic Acid-Rich Bioactive Component of Wheat Bran in a Murine Model of Graft-Versus-Host Disease
by: Silvia Preciado, et al.
Published: (2023-10-01) -
Targeting the Immune System With Mesenchymal Stromal Cell-Derived Extracellular Vesicles: What Is the Cargo's Mechanism of Action?
by: Jorge Diego Martin-Rufino, et al.
Published: (2019-11-01)